Technical analysis of Lyell Immunopharma, Inc. (LYEL): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The company’s lead product candidate include rondecabtagene autoleucel, an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development, which is in pivotal PiNACLE trial in the 3L+ setting and in a Phase 1/2 clinical trial in the 2L setting, as well as a second pivotal trial,...
Price Performance
| 1 month | -31.73% |
| 3 months | -15.38% |
| Year-to-date | -64.98% |
| 1 year | -12.43% |
| 3 years | -66.73% |
| 5 years | -95.44% |
52-Week Range
| 52-week High | $45.00 |
| 52-week Low | $10.46 |
| Avg Volume (90d) | 159K |
Technical Indicators
| SMA 50 | $13.82 |
| SMA 200 | $20.01 |
| Beta | -0.07 |
| 30-day Volatility (annualised) | 69.7% |
| Price vs SMA 50 | -22.0% |
| Price vs SMA 200 | -46.1% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $16.66 | |
| 2025-11 | $24.00 | +44.1% |
| 2025-12 | $30.78 | +28.3% |
| 2026-01 | $24.00 | -22.0% |
| 2026-02 | $24.00 | +0.0% |
| 2026-03 | $20.06 | -16.4% |
| 2026-04 | $19.73 | -1.6% |
| 2026-05 | $17.33 | -12.2% |
| 2026-06 | $14.05 | -18.9% |
| 2026-07 | $12.94 | -7.9% |
| 2026-08 | $14.32 | +10.7% |
| 2026-09 | $10.78 | -24.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $10.78 |
| Market Cap | $264M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.90 |
| EV / EBITDA | -1.08 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.16 |
| Current Ratio | 5.36 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -4.46 |